AU Stock MarketDetailed Quotes

Prescient Therapeutics Ltd (PTX)

Watchlist
  • 0.065
  • -0.003-4.41%
20min DelayNot Open Jun 17 15:59 AET
68.35MMarket Cap-7.22P/E (Static)

About Prescient Therapeutics Ltd Company

Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

Company Profile

SymbolPTX
Company NamePrescient Therapeutics Ltd
Founded1986
MarketASX
Employees1
Fiscal Year Ends06-30
Address385 Bourke Street Suite 2, Level 11
CityMelbourne
CountryAustralia
Zip Code3200
Phone+61 396927222
Share RegistryAUTOMIC REGISTRY SERVICES Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000 02 9698 5414

Company Executives

  • Name
  • Position
  • Salary
  • Melanie Farris
  • Non-Executive Director
  • --
  • James Campbell
  • Non-Executive Director
  • --
  • Gavin James Shepherd
  • Non-Executive Director
  • --
  • Ellen Gwen Feigal
  • Non-Executive Director
  • --
  • Allen James Ebens
  • Non-Executive Director
  • --
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On Tuesday, Trump stated that the United States and Iran had successfully signed a memorandum of understanding online, and that their negoti Show More